Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome
Samo za registrovane korisnike
2011
Autori
Haidara, MohamedMikhailidis, Dimitri P.
Yassin, Hanaa Z.
Dobutović, Branislava
Smiljanić, Katarina
![](/themes/MirageInTOR/images/orcid.png)
Soskic, Sanja
Mousa, Shaker A.
Rizzo, Manfredi
Isenovic, Esma R.
Članak u časopisu (Objavljena verzija)
![](/themes/MirageInTOR//images/creativecommons/arr.png)
Metapodaci
Prikaz svih podataka o dokumentuApstrakt
The metabolic syndrome (MetS) is common, and its associated risk burdens of diabetes and cardiovascular disease (CVD) are a major public health problem. The hypothesis that main constituent parameters of the MetS share common pathophysiologic mechanisms provides a conceptual framework for the future research. Exercise and weight loss can prevent insulin resistance and reduce the risk of diseases associated with the MetS. Interrupting intracellular and extracellular reactive oxygen species (ROS) overproduction could also contribute to normalizing the activation of metabolic pathways leading to the onset of diabetes, endothelial dysfunction, and cardiovascular (CV) complications. On the other hand, it is difficult to counteract the development of CV complications by using conventional antioxidants. Indeed, interest has focused on strategies that enhance the removal of ROS using either antioxidants or drugs that enhance endogenous antioxidant defense. Although these strategies have been e...ffective in laboratory experiments, several clinical trials have shown that they do not reduce CV events, and in some cases antioxidants have actually worsened the outcome. More research is needed in this field.
Ključne reči:
antioxidants / cardiovascular disease / insulin resistance / metabolic syndrome / oxidative stress / reactive oxygen speciesIzvor:
Current Pharmaceutical Design, 2011, 17, 33, 3699-3712Izdavač:
- Bentham Science Publ Ltd, Sharjah
Finansiranje / projekti:
- Hormonska regulacija ekspresije i aktivnosti azot oksid sintaze i natrijum-kalijumove pumpe u eksperimentalnim modelima insulinske rezistencije, dijabetesa i kardiovaskularnih poremećaja (RS-MESTD-Basic Research (BR or ON)-173033)
- Kasr Al-Aini Research Centre
DOI: 10.2174/138161211798220882
ISSN: 1381-6128
PubMed: 22074439
WoS: 000299638000010
Scopus: 2-s2.0-82055206628
Institucija/grupa
TorlakTY - JOUR AU - Haidara, Mohamed AU - Mikhailidis, Dimitri P. AU - Yassin, Hanaa Z. AU - Dobutović, Branislava AU - Smiljanić, Katarina AU - Soskic, Sanja AU - Mousa, Shaker A. AU - Rizzo, Manfredi AU - Isenovic, Esma R. PY - 2011 UR - http://intor.torlakinstitut.com/handle/123456789/786 AB - The metabolic syndrome (MetS) is common, and its associated risk burdens of diabetes and cardiovascular disease (CVD) are a major public health problem. The hypothesis that main constituent parameters of the MetS share common pathophysiologic mechanisms provides a conceptual framework for the future research. Exercise and weight loss can prevent insulin resistance and reduce the risk of diseases associated with the MetS. Interrupting intracellular and extracellular reactive oxygen species (ROS) overproduction could also contribute to normalizing the activation of metabolic pathways leading to the onset of diabetes, endothelial dysfunction, and cardiovascular (CV) complications. On the other hand, it is difficult to counteract the development of CV complications by using conventional antioxidants. Indeed, interest has focused on strategies that enhance the removal of ROS using either antioxidants or drugs that enhance endogenous antioxidant defense. Although these strategies have been effective in laboratory experiments, several clinical trials have shown that they do not reduce CV events, and in some cases antioxidants have actually worsened the outcome. More research is needed in this field. PB - Bentham Science Publ Ltd, Sharjah T2 - Current Pharmaceutical Design T1 - Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome EP - 3712 IS - 33 SP - 3699 VL - 17 DO - 10.2174/138161211798220882 ER -
@article{ author = "Haidara, Mohamed and Mikhailidis, Dimitri P. and Yassin, Hanaa Z. and Dobutović, Branislava and Smiljanić, Katarina and Soskic, Sanja and Mousa, Shaker A. and Rizzo, Manfredi and Isenovic, Esma R.", year = "2011", abstract = "The metabolic syndrome (MetS) is common, and its associated risk burdens of diabetes and cardiovascular disease (CVD) are a major public health problem. The hypothesis that main constituent parameters of the MetS share common pathophysiologic mechanisms provides a conceptual framework for the future research. Exercise and weight loss can prevent insulin resistance and reduce the risk of diseases associated with the MetS. Interrupting intracellular and extracellular reactive oxygen species (ROS) overproduction could also contribute to normalizing the activation of metabolic pathways leading to the onset of diabetes, endothelial dysfunction, and cardiovascular (CV) complications. On the other hand, it is difficult to counteract the development of CV complications by using conventional antioxidants. Indeed, interest has focused on strategies that enhance the removal of ROS using either antioxidants or drugs that enhance endogenous antioxidant defense. Although these strategies have been effective in laboratory experiments, several clinical trials have shown that they do not reduce CV events, and in some cases antioxidants have actually worsened the outcome. More research is needed in this field.", publisher = "Bentham Science Publ Ltd, Sharjah", journal = "Current Pharmaceutical Design", title = "Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome", pages = "3712-3699", number = "33", volume = "17", doi = "10.2174/138161211798220882" }
Haidara, M., Mikhailidis, D. P., Yassin, H. Z., Dobutović, B., Smiljanić, K., Soskic, S., Mousa, S. A., Rizzo, M.,& Isenovic, E. R.. (2011). Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome. in Current Pharmaceutical Design Bentham Science Publ Ltd, Sharjah., 17(33), 3699-3712. https://doi.org/10.2174/138161211798220882
Haidara M, Mikhailidis DP, Yassin HZ, Dobutović B, Smiljanić K, Soskic S, Mousa SA, Rizzo M, Isenovic ER. Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome. in Current Pharmaceutical Design. 2011;17(33):3699-3712. doi:10.2174/138161211798220882 .
Haidara, Mohamed, Mikhailidis, Dimitri P., Yassin, Hanaa Z., Dobutović, Branislava, Smiljanić, Katarina, Soskic, Sanja, Mousa, Shaker A., Rizzo, Manfredi, Isenovic, Esma R., "Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome" in Current Pharmaceutical Design, 17, no. 33 (2011):3699-3712, https://doi.org/10.2174/138161211798220882 . .